From: How COVID-19 pandemic changed our management strategies for amyotrophic lateral sclerosis (ALS) patients: Egyptian study
P-value
Mean ALSFRS-R (Pre-Televisit) ± SD
31.7 ± 6.9
0.1
Mean ALSFRS-R (Televisit) ± SD
29.9 ± 6.5